$MTNB 4 SEC Filings

Filed On	Filing
13 Aug 2026	Form 4: Stern Adam K, 10% owner Acquired 800,000 Warrants to Purchase Common Stock (Other Transaction) ($516K) · Acquired 265 Series C Convertible Preferred Stock (Other Transaction) ($155) · Received 92,100 shares by exercise ($59.4K) · 3 more
13 Aug 2026	Form 4: Sanitam Partners Llc, 10% owner Disposed of 1,406 Series C Convertible Preferred Stock (Other Transaction) ($824) · Disposed of 4,798,636 Warrants to Purchase Common Stock (Other Transaction) ($3.09M)
02 May 2025	Form 4: Neugeboren Edward, Director Granted 11,600 Stock Option (right to Buy)
02 May 2025	Form 4: Smith Robin L, Director Granted 11,600 Stock Option (right to Buy)
02 May 2025	Form 4: D An Evelyn, Director Granted 11,600 Stock Option (right to Buy)
02 May 2025	Form 4: Jabbour Jerome D, Director Granted 70,100 Stock Option (right to Buy)
02 May 2025	Form 4: Murphy Keith, Director Granted 11,600 Stock Option (right to Buy)
15 Dec 2023	Form 4: Hoover Thomas, Chief Business Officer Granted 1,000,000 Stock Option (right to Buy)
15 Dec 2023	Form 4: Kucinski Keith A, Chief Financial Officer Granted 1,000,000 Stock Option (right to Buy)
15 Dec 2023	Form 4: Liu Hui, Chief Technology Officer Granted 1,000,000 Stock Option (right to Buy)
15 Dec 2023	Form 4: Jabbour Jerome D, Director Granted 3,500,000 Stock Option (right to Buy)
15 Dec 2023	Form 4: Ferguson James J. Iii, Chief Medical Officer Granted 1,200,000 Stock Option (right to Buy)
15 Dec 2023	Form 4: Matkovits Theresa, Chief Development Officer Granted 1,300,000 Stock Option (right to Buy)
03 Nov 2023	Form 4: Corzo Kathryn Penkus, Director Granted 437,244 Stock option (right to buy)
03 Nov 2023	Form 4: Ende Eric J, Director Granted 437,244 Stock option (right to buy)
03 Nov 2023	Form 4: Wikler Matthew, Director Granted 437,244 Stock option (right to buy)
03 Nov 2023	Form 4: Conrad Herbert J, Director Granted 437,244 Stock option (right to buy)
03 Nov 2023	Form 4: Scibetta James S, Director Granted 437,244 Stock option (right to buy)
03 Nov 2023	Form 4: Giordano Natasha, Director Granted 437,244 Stock option (right to buy)
22 Dec 2022	Form 4: Matkovits Theresa, Chief Development Officer Granted 625,000 Stock Option (right to Buy)

Comments